Investor Presentation

October 26, 2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Compliance & Legal Regulatory Listing & Compliance Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra East, Mumbai 400 051 Stock Code: 543233 Stock Symbol: CHEMCON Dear Sir/Madam, Sub: Investor Presentation Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing obligations and Disclosure Requirements), Regulations, 2015, please find enclose herewith the “Investor Presentation” for October 2026. The aforementioned presentation is also being uploaded on the Company’s website at www.cscpl.com. We request you to take the above on your records. Thanking you, Yours faithfully, For Chemcon Speciality Chemicals Limited Shahilkumar Kapatel Company Secretary & Compliance Officer Membership No.: A52211 Chemcon Speciality Chemicals Limited Investor Presentation – October 2026 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Chemcon Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Q2 & H1 FY27 Performance Highlights Q2 FY27 Performance Highlights “Overall business performance recorded a healthy growth during Q2 and H1 FY27, despite moderation in key chemicals prices compared to the previous quarter and weak offtake from Inorganic Chemicals customers. The Company reported revenue of ₹65 crore in Q2 FY27, registering 22% YoY growth, and ₹132 crore in H1 FY27, reflecting 23% YoY growth. The Organic Chemicals segment delivered a strong performance, driven by steady demand and a gradual improvement in realizations over the past few months for HMDS, CMIC, 2-Bromo and Bromobenzene across pharmaceutical, agrochemical and aromatics customers. The Inorganic Chemicals segment was largely impacted by subdued demand, crude oil price volatility, geopolitical uncertainties and reduced oil drilling activity, which led to lower bromide volumes during the quarter. Despite continued uncertainty in the operating environment, the Company remains optimistic about its growth prospects, supported by a healthy balance sheet, a diversified product portfolio, recovery in demand and the commissioning of the upcoming new unit. The Company remains well-positioned to capitalize on emerging growth opportunities while maintaining a disciplined and cautious approach.” Mr. Kamal Aggarwal, Chairman & Managing Director Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides 4 Financial Highlights Revenue from EBITDA (Rs. Cr) PAT (Rs. Cr) Operations (Rs. Cr) 65.4 11.0 7.5 53.7 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 100% 100% 100% 100% 2,059 Others 13% Export 39% 39% 17% 5% Inorganic Chemicals 653 1,609 Inorganic Chemicals Organic Chemicals 77% 82% Domestic 61% 61% Organic Chemicals 1,406 1,400 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides Export data are inclusive of Deemed Exports 5 Financial Highlights Revenue from EBITDA (Rs. Cr) PAT (Rs. Cr) Operations (Rs. Cr) 131.9 26.5 18.5 107.2 12.1 14.6 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 100% 100% 100% 100% 4,157 Others 6% 12% 3,675 Export 35% 35% 16% 9% Inorganic Chemicals 1,415 Inorganic Chemicals 1,039 Organic Chemicals 78% 79% Domestic 65% 65% Organic Chemicals 2,742 2,636 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 Organic chemicals refers to HMDS, CMIC, Bromobenzene and 2 Bromo whereas Inorganic chemicals refer to Bromides Export data are inclusive of Deemed Exports 6 Profit & Loss Statement Particulars (Rs. Crs) Q2 FY27 Q2 FY26 Y-o-Y H1 FY27 H1 FY26 Y-o-Y Revenuefrom Operations 65.4 53.7 22% 131.9 107.2 23% Cost of Goods Sold 40.1 34.2 77.0 65.7 Employee Cost 5.4 4.9 11.1 9.9 Other Expenses 8.9 7.7 17.4 17.0 EBITDA 11.0 6.9 61% 26.5 14.6 81% EBITDA Margin 16.9% 12.8% 20.1% 13.6% Other Income 3.6 3.9 7.3 7.7 Depreciation 3.8 2.8 7.6 5.5 EBIT 10.8 8.0 26.2 16.8 Finance Cost 0.7 0.1 1.5 0.4 Profit before Tax 10.1 7.9 24.7 16.4 Tax 2.6 2.2 6.2 4.2 PAT 7.5 5.7 31% 18.5 12.1 52% PAT Margin % 11.5% 10.7% 14.0% 11.3% Basic EPS 2.05 1.57 5.05 3.31 Balance Sheet ASSETS (Rs. Crs) Sep-26 Mar-26 EQUITY AND LIABILITIES Sep-26 Mar-26 Non-Current Assets EQUITY AND LIABILITIES Equity a) Property, Plant And Equipment 189.9 194.6 a) Equity Share Capital 36.6 36.6 b) Capital Work in Progress 21.0 20.9 b) Other Equity 441.2 446.5 c) Right Of Use Asset - - Total Equity 477.8 483.1 d) Intangible Assets 0.0 0.0 Liabilities e) Investments 3.7 2.6 Non-Current Liabilities f) Other Financial Assets 1.1 1.1 a) Financial Liabilities g) Other Non-Current Assets 3.4 2.7 i) Borrowings - 0.1 ii) Lease Liabilities - - iii) Other financial liabilities - - Sub-Total - Non-Current Assets 219.2 222.0 b) Non current Provisions 0.4 0.3 c) Deferred Tax Liabilities (Net) 5.7 5.5 Current Assets d) Other Non-current liabilities 0.3 0.4 a) Inventories 65.4 67.3 Sub-Total - Non-Current Liabilities 6.5 6.3 b) Financial Assets Current Liabilities i) Investments 7.2 7.8 a) Financial Liabilities ii) Trade Receivables 42.1 63.5 i) Borrowing 27.3 53.1 iii) Cash And Cash Equivalents 11.3 10.4 ii) Trade Payables 16.6 17.9 iii) Other Financial Liabilities 4.0 3.4 iv) Bank Balances 168.3 178.2 iv) Lease Liabilities - - v) Other Financial Assets 12.6 8.5 b) Other Current Liabilities 2.5 3.8 c) Other Current Assets 11.5 9.6 c) Short Term Provisions 0.5 0.3 d) Current tax assets - 0.6 d) Current tax Liabilities 2.5 - Sub-Total - Current Assets 318.4 346.0 Sub-Total - Current Liabilities 53.3 78.5 Total - Assets 537.6 568.0 Total - Equity And Liabilities 537.6 568.0 Cash Flow Statement Particulars (Rs. Crs.) Sep-26 Sep-25 Net Profit Before Tax 24.7 16.4 Adjustments for: Non C [Showing first 8,000 characters — download PDF for full document]